Vincent L, Gras L, Ceballos P, Finke J, et al. Daratumumab after allogeneic hematopoietic cell transplantation for multiple
myeloma is safe and synergies with pre-existing chronic graft versus host
disease. A retrospective study from the CMWP EBMT. Bone Marrow Transplant 2022 Jan 10. pii: 10.1038/s41409-021-01560.
PMID: 35013536